The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
Who can participate
Inclusion Criteria:
* According to the IFU
Exclusion Criteria:
* According to the IFU
Locations
7
Australia (1)
Cairns Hospital
Cairns
COMPLETED
Germany (1)
Heart Center Segeberger Kliniken
Bad Segeberg
Italy (1)
Centro Cardiologico Monzino
Milan , Lombardy
Latvia (1)
Daugavpils Regional Hospital
Daugavpils
COMPLETED
Poland (1)
1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ w Lublinie